On March, 15, 2018, the first participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, …
On February 24, 2017, investigators gathered for the formal closeout of our Phase 2 study of MDMA-assisted psychotherapy in 23 subjects with chronic PTSD in Boulder, Colorado, led by Principal Investigator …
On February 2 and February 7, 2017, the eighth and ninth of 10 participants completed their 12-month follow-up interviews in our Israeli Phase 2 study of MDMA-assisted psychotherapy for PTSD. The seventh …
On February 1, 2017, the final participant completed their 12-month follow-up interview in our Phase 2 study of MDMA-assisted psychotherapy in 23 subjects with chronic PTSD in Boulder, Colorado led by …
On January 3, 2017, the Institutional Review Board (IRB) at Emory University approved the first protocol amendment for our upcoming Phase 1 study onthe effect of MDMA on startle testing in healthy volunteers. …
On November 30, 2016, the FDA cleared the upcoming MAPS-sponsored Phase 1 study on the effect of MDMA on startle testing in healthy volunteers. Principal Investigator Barbara Rothbaum, Ph.D., a leading …
On November 28, 2016, the 21th participant out of 23 completed their 12-month follow-up interview in our Phase 2 study of MDMA-assisted psychotherapy in 23 subjects with chronic PTSD in Boulder, Colorado, …
On November 10 and November 28, 2016, the fifth and sixth of 10 participants completed their 12-month follow-up interviews in ourIsraeli Phase 2 study of MDMA-assisted psychotherapy for PTSD. Led by Principal …
On November 27, 2016, investigators gathered for the formal closeout of our Phase 2 pilot study of MDMA-assisted psychotherapy for PTSD in Vancouver, Canada. Conducted by Clinical Trial Leader Alli Feduccia, …
On October 17, 2016, the sixth and final participant completed their 12-month follow-up interview in our Phase 2 pilot study of MDMA-assisted psychotherapy for PTSD in Vancouver, Canada. All participants …
On October 21, 2016, the fourth of 10 participants completed their 12-month follow-up interview in our Israeli Phase 2 study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Moshe …
On October 17, 2016, the 20th participant out of 23 completed their 12-month follow-up interview in our Phase 2 study of MDMA-assisted psychotherapy in 23 subjects with chronic, treatment-resistant PTSD …